| Autor: |
Bhar, Saleh, Zhou, Fujun, Reineke, Lucas C., Morris, Danna K., Khincha, Payal P., Giri, Neelam, Mirabello, Lisa, Bergstrom, Katie, Lemon, Laramie D., Williams, Christopher L., Toh, Yukimatsu, Elghetany, M. Tarek, Lloyd, Richard E., Alter, Blanche P., Savage, Sharon A., Bertuch, Alison A. |
| Zdroj: |
Human Mutation; Nov2020, Vol. 41 Issue 11, p1918-1930, 13p |
| Abstrakt: |
Diamond–Blackfan anemia (DBA) is a ribosomopathy of variable expressivity and penetrance characterized by red cell aplasia, congenital anomalies, and predisposition to certain cancers, including early‐onset colorectal cancer (CRC). DBA is primarily caused by a dominant mutation of a ribosomal protein (RP) gene, although approximately 20% of patients remain genetically uncharacterized despite exome sequencing and copy number analysis. Although somatic loss‐of‐function mutations in RP genes have been reported in sporadic cancers, with the exceptions of 5q‐myelodysplastic syndrome (RPS14) and microsatellite unstable CRC (RPL22), these cancers are not enriched in DBA. Conversely, pathogenic variants in RPS20 were previously implicated in familial CRC; however, none of the reported individuals had classical DBA features. We describe two unrelated children with DBA lacking variants in known DBA genes who were found by exome sequencing to have de novo novel missense variants in RPS20. The variants affect the same amino acid but result in different substitutions and reduce the RPS20 protein level. Yeast models with mutation of the cognate residue resulted in defects in growth, ribosome biogenesis, and polysome formation. These findings expand the phenotypic spectrum of RPS20 mutation beyond familial CRC to include DBA, which itself is associated with increased risk of CRC. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text